1. IDO/kynurenine pathway in cancer: possible therapeutic approaches
   Eslam E. Abd El-Fattah, 2022, Journal of Translational Medicine CrossRef
2. 1‐L‐MT, an IDO inhibitor, prevented colitis‐associated cancer by inducing CDC20 inhibition‐mediated mitotic death of colon cancer cells
   Xiuting Liu et al, 2018, International Journal of Cancer CrossRef
3. A new cancer immunotherapy via simultaneous DC‐mobilization and DC‐targeted IDO gene silencing using an immune‐stimulatory nanosystem
   Yujuan Zhang et al, 2018, International Journal of Cancer CrossRef
4. Gene silencing of indoleamine 2,3‑dioxygenase 1 inhibits lung cancer growth by suppressing T‑cell exhaustion
   Ke Shang et al, 2020, Oncology Letters CrossRef
5. Combination of apatinib with apo-IDO1 inhibitor for the treatment of colorectal cancer
   Longbo Yu et al, 2022, International Immunopharmacology CrossRef
6. What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?
   Theodoros Eleftheriadis, 2018, Frontiers in Immunology CrossRef
7. Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines
   Sara Paccosi et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef
8. Not Only Immune Escape—The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis
   Iwona Kwiatkowska et al, 2021, Cancers CrossRef
9. The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment
   Xinting Huang et al, 2022, Cancers CrossRef
10. Self‐Splittable Transcytosis Nanoraspberry for NIR‐II Photo‐Immunometabolic Cancer Therapy in Deep Tumor Tissue
    Li Wang et al, 2022, Advanced Science CrossRef
11. Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
    Xiaotian Song et al, 2021, Frontiers in Immunology CrossRef
12. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer
    Xinlong Zang et al, 2022, Journal of Materials Chemistry B CrossRef
13. Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity
    Yujuan Zhang et al, 2020, Frontiers in Immunology CrossRef
14. The exploitation of enzyme-based cancer immunotherapy
    Gourav Chandan et al, 2022, Human Cell CrossRef
15. Effects of gene silencing of indoleamine 2,3-dioxygenase 1 combined with rosmarinic acid on tumor immune microenvironment in H22 tumor-bearing mice
    Wen Cao et al, 2023, International Immunopharmacology CrossRef